Mindfulness for Smoking Cessation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help people with cancer quit smoking using a mindfulness approach delivered through a smartphone app. Participants will either use the mindfulness app or receive standard care through Quitline, a smoking cessation service. The trial targets individuals diagnosed with cancer who have smoked within the last month and are eager to quit soon. Participants must have a smartphone and be willing to install the app. As an unphased trial, this study provides a unique opportunity to explore innovative methods for smoking cessation.
Do I have to stop taking my current medications for the trial?
The trial requires that you are not currently using smoking cessation medications. Other medications are not mentioned, so it's unclear if you need to stop them.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has extensively studied the use of mindfulness to help people quit smoking. However, these studies have not found strong evidence that mindfulness aids in quitting smoking or improves mental health. Mindfulness practices are generally safe and well-tolerated, with no major reports of negative effects. While mindfulness might not significantly enhance quitting success, it remains safe for participants to try.12345
Why are researchers excited about this trial?
Researchers are excited about using mindfulness for smoking cessation because it offers a unique approach compared to traditional methods like nicotine replacement therapy and behavioral counseling. Mindfulness helps individuals become more aware of their cravings and reactions, allowing them to manage urges without immediately reaching for a cigarette. This technique is often delivered through a mobile app, making it easily accessible and convenient for users to integrate into their daily lives. Unlike standard treatments that primarily target the physical aspects of addiction, mindfulness focuses on the psychological elements, potentially leading to a more holistic approach to quitting smoking.
What evidence suggests that this trial's treatments could be effective for smoking cessation?
This trial will compare mindfulness therapy with standard care for smoking cessation. Research has shown that mindfulness therapy can help people break the link between cravings and smoking. However, some studies have not found strong evidence of its effectiveness for quitting smoking. For instance, one study did not show significant improvements in quitting rates or reducing the number of cigarettes compared to other methods. While mindfulness might help some individuals, results can vary. Thus, although mindfulness has potential, the evidence remains inconclusive.13567
Who Is on the Research Team?
Min-Jeong Yang, PhD
Principal Investigator
Rutgers, The State University of New Jersey
Are You a Good Fit for This Trial?
This trial is for adult cancer survivors who smoke at least one cigarette a day, are motivated to quit within the next month, have a smartphone, and can communicate in English. It's not for those using cessation meds, pregnant or lactating individuals, people with psychosis, or anyone in another quit-smoking program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Mindfulness
Trial Overview
The study is testing a new smartphone app designed to help cancer survivors stop smoking. Participants will use mindfulness techniques through the app and may also receive support from Quitline services as part of their treatment.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app.
Participants will be referred to Quitline to receive standard care for smoking cessation.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Rutgers, The State University of New Jersey
Lead Sponsor
National Cancer Institute (NCI)
Collaborator
Citations
Mindfulness-Based Smoking Cessation Delivered Through ...
The primary outcomes are biochemically verified smoking abstinence at 8, 12, and 24 weeks after the start of treatment. Secondary outcomes include the frequency ...
Mindfulness for smoking cessation - Jackson, S - 2022
We did not detect a clear benefit of mindfulness‐based smoking cessation interventions for increasing smoking quit rates or changing mental ...
A Mindfulness Based Application for Smoking Cessation
Mindfulness therapy has been found to be effective in teaching strategies to decouple the association between craving and smoking. Mindfulness based smoking ...
Efficacy of mindfulness meditation for smoking cessation
Overall, mindfulness meditation did not have significant effects on abstinence or cigarettes per day, relative to comparator groups.
Mindfulness for smoking cessation - PMC - PubMed Central
We did not find clear evidence that mindfulness helped people to stop smoking. When we grouped studies by the type of mindfulness‐based intervention people ...
Outcomes of a Comprehensive Mobile Smoking Cessation ...
This study aimed to compare engagement, retention, attitudes toward quitting smoking, smoking behavior, and participant feedback between Pivot and QuitGuide.
NCT05440903 | Mindfulness Training for Smoking Cessation
During the study, participants will complete baseline questionnaires, followed by two weeks of daily MT or control training and self-report on questionnaires ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.